Moelis & Co Stock: price and insider trades · United States · SEC (Form 4)Track the Moelis & Co share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Finance & Banking sector, Moelis & Co has logged 214 insider filings. Market capitalisation: €5.1bn. The latest transaction was filed on 31 August 2026 (Cession). Among the most active insiders: Shropshire Kenneth. The full history is openly available.
Analyst consensus: bullish or bearish? Analysts rate Moelis & Co Hold (neutral), based on 10 analysts. Average price target: US$72.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,597 of 29,062 companies
FCF yld 11%
Earn yld 4.6%
EV/EBITDA 18.7x
ROE 41%
Gross mgn 33%
Net mgn 15%
Debt/EBITDA 0.9x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 August 2026
All Executives214 Thresholds0 Prospectus0 Other0
Declarations 214 total
▼ Director · Executives · 27 Aug 2026
1,881 shares @ US$69.06 Class A Common Stock SEC:0001193125-26-376994:0
▼ General Counsel, Secretary · Executives · 4 Aug 2026
4,850 shares @ US$69.30 0.0065% mcap 23.2% of flow Class A Common Stock SEC:0001193125-26-338385:0
◆ Director · Executives · 1 Jul 2026
1,545 shares 2026 Annual Restricted Stock Units SEC:0001193125-26-296362:0
◆ Director · Executives · 1 Jul 2026
200 shares 2026 Elective Restricted Stock Units SEC:0001193125-26-296356:1
◆ Director · Executives · 1 Jul 2026
1,623 shares 2026 Annual Restricted Stock Units SEC:0001193125-26-296361:0
◆ Director · Executives · 1 Jul 2026
1,700 shares 2026 Annual Restricted Stock Units SEC:0001193125-26-296356:0
◆ Director · Executives · 1 Jul 2026
1,623 shares 2026 Annual Restricted Stock Units SEC:0001193125-26-296357:0
◆ Director · Executives · 1 Jul 2026
1,777 shares 2026 Elective Restricted Stock Units SEC:0001193125-26-296357:1
◆ Director · Executives · 18 Jun 2026
15.96 shares 2025 Annual Restricted Stock Units SEC:0001193125-26-279856:0
◆ Director · Executives · 26 Mar 2026
14.84 shares 2024 Annual Restricted Stock Units SEC:0001193125-26-132240:0
◆ Director · Executives · 26 Mar 2026
25.19 shares 2024 Annual Restricted Stock Units SEC:0001193125-26-132296:0
◆ Director · Executives · 26 Mar 2026
24.05 shares 2024 Annual Restricted Stock Units SEC:0001193125-26-132288:0
◆ Director · Executives · 26 Mar 2026
19.11 shares 2025 Annual Restricted Stock Units SEC:0001193125-26-132242:0
◇ Principal Accounting Officer · Executives · 19 Feb 2026
61.43 shares Class A Common Stock SEC:0001193125-26-064637:0
◇ General Counsel, Secretary · Executives · 19 Feb 2026
9,218.9 shares Class A Common Stock SEC:0001193125-26-064633:0
◇ Chief Financial Officer · Executives · 19 Feb 2026
2,179.3 shares Class A Common Stock SEC:0001193125-26-064631:0
◇ Vice Chairman, MD · Executives · 19 Feb 2026
32,367.97 shares Class A Common Stock SEC:0001193125-26-064625:0
◇ Chief Operating Officer · Executives · 19 Feb 2026
4,885.48 shares Class A Common Stock SEC:0001193125-26-064629:0
◆ Director · Executives · 4 Dec 2025
20.81 shares 2024 Annual Restricted Stock Units SEC:0001193125-25-309959:0
◆ Director · Executives · 4 Dec 2025
19.87 shares 2024 Annual Restricted Stock Units SEC:0001193125-25-309957:0
◆ Director · Executives · 4 Dec 2025
15.79 shares 2025 Annual Restricted Stock Units SEC:0001193125-25-309955:0
◇ Vice Chairman, MD · Executives · 5 Dec 2025
668.41 shares Class A Common Stock SEC:0001193125-25-309954:0
◆ Director · Executives · 4 Dec 2025
12.26 shares 2024 Annual Restricted Stock Units SEC:0001193125-25-309953:0
◇ Executive Chairman · Executives · 30 Oct 2025
73 shares Class A Common Stock SEC:0001193125-25-262756:0
◆ Director · Executives · 18 Sept 2025
17.64 shares 2024 Annual Restricted Stock Units SEC:0001193125-25-209338:0
25 of 214 declarations
Load more (189 remaining) 关于 Moelis & Co Moelis & Co (NYSE: MC) 是一家领先的独立投资银行,总部位于美国并在纽约证券交易所上市。该公司由 Ken Moelis 于 2007 年创立,其核心业务模式是“咨询优先”,强调战略咨询而非资产负债表密集型交易或借贷。其全球总部位于纽约,并通过约 23 个分支机构网络运营,服务于多元化的客户群,包括跨多个地区的 корпорации、金融赞助商和机构。([moelis.com](https://www.moelis.com/?utm_source=openai))
该公司的核心业务围绕四大咨询支柱展开:并购和战略咨询、资本结构咨询、资本市场以及私募资本咨询。实际上,Moelis 为客户提供收购、资产剥离、资本重组、重组、再融资以及精选资本市场交易方面的咨询服务。这种业务模式产生的费用收入与交易量和时间挂钩,使得业绩对市场活动和交易完成速度高度敏感。([moelis.com](https://www.moelis.com/our-business/?utm_source=openai))
从竞争角度来看,Moelis 是全球最知名的独立并购咨询机构之一。它与其它顶级精品投行以及大型银行的咨询部门竞争。其竞争优势通常在于其由高级银行家主导的客户覆盖、行业专业化以及处理复杂跨境业务的能力。该公司将自身定位为一个拥有深厚客户关系和广泛行业覆盖的全球平台,这支持了其在高价值企业融资业务中的地位。([moelis.com](https://www.moelis.com/?utm_source=openai))
从地理上看,该业务是国际性的,纽约是全球中心,并在主要金融和商业中心设有其他办事处。Moelis 还利用战略联盟,包括在澳大利亚和墨西哥的联盟,以扩大其咨询范围。对于投资者而言,关键在于 Moelis 是一个周期性金融服务公司:盈利势头严重依赖并购条件、资本市场情绪以及公司吸引和留住高级咨询人才的能力。([moelis.com](https://www.moelis.com/?utm_source=openai))
近期发展具有建设性。2026 年 2 月,Moelis 公布了 2025 财年显著改善的业绩,包括更高的收入和更强的调整后税前利润率,同时通过定期季度股息和新的股票回购授权增加了资本回报。2026 年,该公司还继续提拔董事总经理并扩大其咨询团队,突显了有机增长势头。总体而言,最新披露表明该公司运营杠杆有所改善,但仍受美国及海外交易周期的影响。([investors.moelis.com](https://investors.moelis.com/press-releases/news-details/2026/Moelis--Company-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-Declares-Regular-Quarterly-Dividend-of-0-65-Per-Share-and-Board-Approves-New-300-Million-Share-Repurchase-Authorization/default.aspx?utm_source=openai))